Literature DB >> 27600517

Assessment of Motor Units in Neuromuscular Disease.

Robert D Henderson1, Pamela A McCombe2.   

Abstract

The motor unit comprises the anterior horn cell, its axon, and the muscle fibers that it innervates. Although the true number of motor units is unknown, the number of motor units appears to vary greatly between different muscles and between different individuals. Assessment of the number and function of motor units is needed in diseases of the anterior horn cell and other motor nerve disorders. Amyotrophic lateral sclerosis is the most important disease of anterior horn cells. The need for an effective biomarker for assessing disease progression and for use in clinical trials in amyotrophic lateral sclerosis has stimulated the study of methods to measure the number of motor units. Since 1970 a number of different methods, including the incremental, F-wave, multipoint, and statistical methods, have been developed but none has achieved widespread applicability. Two methods (MUNIX and the multipoint incremental method) are in current use across multiple centres and are discussed in detail in this review, together with other recently published methods. Imaging with magnetic resonance and ultrasound is increasingly being applied to this area. Motor unit number estimates have also been applied to other neuromuscular diseases such as spinal muscular atrophy, compression neuropathies, and prior poliomyelitis. The need for an objective measure for the assessment of motor units remains tantalizingly close but unfulfilled in 2016.

Entities:  

Keywords:  ALS; amyotrophic lateral sclerosis; biomarker; electrophysiology; motor unit

Mesh:

Substances:

Year:  2017        PMID: 27600517      PMCID: PMC5233620          DOI: 10.1007/s13311-016-0473-z

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  106 in total

1.  A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis.

Authors: 
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

2.  Collateral regeneration in partially denervated muscles.

Authors:  G WOHLFART
Journal:  Neurology       Date:  1958-03       Impact factor: 9.910

3.  Muscle changes in amyotrophic lateral sclerosis: a longitudinal ultrasonography study.

Authors:  Ilse M P Arts; Sebastiaan Overeem; Sigrid Pillen; H Jurgen Schelhaas; Machiel J Zwarts
Journal:  Clin Neurophysiol       Date:  2011-03       Impact factor: 3.708

4.  A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.

Authors:  Michael D Weiss; Eric A Macklin; Zachary Simmons; Angela S Knox; David J Greenblatt; Nazem Atassi; Michael Graves; Nicholas Parziale; Johnny S Salameh; Colin Quinn; Robert H Brown; Jane B Distad; Jaya Trivedi; Jeremy M Shefner; Richard J Barohn; Alan Pestronk; Andrea Swenson; Merit E Cudkowicz
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

5.  Estimation of the number and size of human flexor digiti minimi muscle motor units using histological methods.

Authors:  H Santo Neto; V C de Carvalho; M J Marques
Journal:  Muscle Nerve       Date:  1998-01       Impact factor: 3.217

6.  Neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  R A Maselli; R L Wollman; C Leung; B Distad; S Palombi; D P Richman; E F Salazar-Grueso; R P Roos
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

7.  Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis.

Authors:  H Askmark; S M Aquilonius; P G Gillberg; P Hartvig; P Hilton-Brown; B Lindström; D Nilsson; E Stålberg; T Winkler
Journal:  Acta Neurol Scand       Date:  1990-10       Impact factor: 3.209

8.  A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

Authors:  M E Cudkowicz; J M Shefner; D A Schoenfeld; R H Brown; H Johnson; M Qureshi; M Jacobs; J D Rothstein; S H Appel; R M Pascuzzi; T D Heiman-Patterson; P D Donofrio; W S David; J A Russell; R Tandan; E P Pioro; K J Felice; J Rosenfeld; R N Mandler; G M Sachs; W G Bradley; E M Raynor; G D Baquis; J M Belsh; S Novella; J Goldstein; J Hulihan
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

9.  Excitability properties of single human motor axons: are all axons identical?

Authors:  Lydia P Kudina; Regina E Andreeva
Journal:  Front Cell Neurosci       Date:  2014-03-19       Impact factor: 5.505

10.  MRI quantifies neuromuscular disease progression.

Authors:  Sean C Forbes; Rebecca J Willcocks; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Lancet Neurol       Date:  2015-11-06       Impact factor: 44.182

View more
  6 in total

1.  An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial Introduction.

Authors:  Jeremy M Shefner; Marwan N Sabbagh
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

2.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

Review 3.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

Review 4.  Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy.

Authors:  Didu S T Kariyawasam; Arlene D'Silva; Cindy Lin; Monique M Ryan; Michelle A Farrar
Journal:  Front Neurol       Date:  2019-08-19       Impact factor: 4.003

5.  Application Value of the Motor Unit Number Index in Patients With Kennedy Disease.

Authors:  Shuo Zhang; Xin Yang; Yingsheng Xu; Yongmei Luo; Dongsheng Fan; Xiaoxuan Liu
Journal:  Front Neurol       Date:  2021-12-21       Impact factor: 4.003

6.  A randomized double blinded placebo controlled study to evaluate motor unit abnormalities after experimentally induced sensitization using capsaicin.

Authors:  Valerie Evans; Ryan G L Koh; Felipe C K Duarte; Lukas Linde; Mohammadreza Amiri; Dinesh Kumbhare
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.